Adam Maeder
Stock Analyst at Piper Sandler
(3.90)
# 653
Out of 5,090 analysts
100
Total ratings
55.22%
Success rate
9.76%
Average return
Main Sectors:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NYXH Nyxoah | Reiterates: Overweight | $12 → $9 | $4.77 | +88.68% | 9 | Nov 14, 2025 | |
| SGHT Sight Sciences | Maintains: Neutral | $4 → $5 | $8.35 | -40.12% | 2 | Nov 7, 2025 | |
| TCMD Tactile Systems Technology | Reiterates: Neutral | $14 → $20 | $26.67 | -25.01% | 4 | Nov 4, 2025 | |
| INSP Inspire Medical Systems | Reiterates: Overweight | $150 → $135 | $140.03 | -3.59% | 16 | Nov 4, 2025 | |
| EW Edwards Lifesciences | Reiterates: Overweight | $90 → $95 | $85.78 | +10.75% | 17 | Oct 31, 2025 | |
| ISRG Intuitive Surgical | Reiterates: Overweight | $595 → $610 | $568.65 | +7.27% | 21 | Oct 22, 2025 | |
| RBOT Vicarious Surgical | Maintains: Neutral | $8.5 → $7 | $3.00 | +133.33% | 8 | Aug 13, 2025 | |
| RMD ResMed | Maintains: Neutral | $248 → $270 | $251.51 | +7.35% | 4 | Aug 1, 2025 | |
| RXST RxSight | Maintains: Neutral | $18 → $10 | $12.46 | -19.74% | 2 | Jul 9, 2025 | |
| NSPR InspireMD | Maintains: Overweight | $4.5 → $4 | $1.91 | +109.42% | 4 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $133 → $145 | $125.40 | +15.63% | 3 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $20 → $21 | $22.32 | -5.91% | 2 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 → $8 | $1.47 | +446.08% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $2.43 | +105.76% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $10 → $18 | $1.06 | +1,598.11% | 2 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $104 → $99 | $63.67 | +55.49% | 3 | May 5, 2022 |
Nyxoah
Nov 14, 2025
Reiterates: Overweight
Price Target: $12 → $9
Current: $4.77
Upside: +88.68%
Sight Sciences
Nov 7, 2025
Maintains: Neutral
Price Target: $4 → $5
Current: $8.35
Upside: -40.12%
Tactile Systems Technology
Nov 4, 2025
Reiterates: Neutral
Price Target: $14 → $20
Current: $26.67
Upside: -25.01%
Inspire Medical Systems
Nov 4, 2025
Reiterates: Overweight
Price Target: $150 → $135
Current: $140.03
Upside: -3.59%
Edwards Lifesciences
Oct 31, 2025
Reiterates: Overweight
Price Target: $90 → $95
Current: $85.78
Upside: +10.75%
Intuitive Surgical
Oct 22, 2025
Reiterates: Overweight
Price Target: $595 → $610
Current: $568.65
Upside: +7.27%
Vicarious Surgical
Aug 13, 2025
Maintains: Neutral
Price Target: $8.5 → $7
Current: $3.00
Upside: +133.33%
ResMed
Aug 1, 2025
Maintains: Neutral
Price Target: $248 → $270
Current: $251.51
Upside: +7.35%
RxSight
Jul 9, 2025
Maintains: Neutral
Price Target: $18 → $10
Current: $12.46
Upside: -19.74%
InspireMD
May 12, 2025
Maintains: Overweight
Price Target: $4.5 → $4
Current: $1.91
Upside: +109.42%
Apr 17, 2025
Reiterates: Overweight
Price Target: $133 → $145
Current: $125.40
Upside: +15.63%
May 22, 2024
Maintains: Hold
Price Target: $20 → $21
Current: $22.32
Upside: -5.91%
Mar 6, 2024
Reiterates: Overweight
Price Target: $7 → $8
Current: $1.47
Upside: +446.08%
Mar 6, 2023
Maintains: Overweight
Price Target: $6 → $5
Current: $2.43
Upside: +105.76%
Jan 6, 2023
Upgrades: Overweight
Price Target: $10 → $18
Current: $1.06
Upside: +1,598.11%
May 5, 2022
Maintains: Overweight
Price Target: $104 → $99
Current: $63.67
Upside: +55.49%